查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1534903

羥考酮市場：現況分析與預測（2024-2032）

Oxycodone Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 134 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

在預測期（2024-2032年），羥考酮市場預計將以 5.13%的年複合成長率顯著成長。這可能是因為人口老化以及關節炎和腰痛等慢性疼痛的發生率不斷增加，這也增加了對羥考酮等鴉片類止痛藥的需求。美國國立衛生研究院（NIH）（.gov）在一份報告中指出，到2023年，慢性疼痛新發病例將達到每年每 1000 人 52.4 例的高水準。相較之下，其他常見慢性疾病如糖尿病（7.1例/1000人/年）、憂鬱症（15.9例/1000人/年）和高血壓（45.3例/1000人/年）。此外，對羥考酮的需求增加導致製造和銷售該藥物的製藥公司收入增加。

依類型，市場分為長效羥考酮和短效羥考酮。2023年，長效羥考酮將佔據市場。它主要適用於患有慢性疼痛（例如關節炎、癌症或嚴重背痛）的患者，這些患者需要長期緩解疼痛才能過上美好的生活。羥考酮的易用性和效率會影響處方者選擇它而不是其他形式的鴉片類藥物，提高處方率。

根據應用，市場分為疼痛管理和戒癮。到2023年，疼痛管理將佔據壓倒性的市場。關節炎、纖維肌痛和神經性疼痛等慢性疾病的盛行率不斷上升，也增加了對止痛產品的需求，創造了對羥考酮的需求。例如，在美國（NHIS），2019年至2021年，大約5.4%的18 歲至44 歲成年人報告患有關節炎，而在45 歲至64 歲的成年人中，四分之一（26.0%）報告指出患有關節炎。此外，隨著阿片類藥物在疼痛管理中的使用增加，以及人們對控制疼痛以改善患者治療效果的認識不斷提高，羥考酮等鴉片類藥物現在比以往任何時候都更容易獲得和使用。

根據通路，市場分為醫院藥房、零售藥房和網路藥房。預計在預測期內（2024-2032年），醫院將以顯著的年複合成長率成長。由於慢性和急性病症的手術和住院治療的增加，醫院環境中對充分緩解疼痛的需求也在增加，增加了對羥考酮的需求。例如，根據世界衛生組織（WHO）表示，到2023年，全球每年將進行超過 3億例外科手術。此外，醫院藥局提供了一個重要的介面，以教育患者如何正確使用鴉片類藥物的處方劑量並避免濫用風險。

為了更了解羥考酮的市場介紹，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、法國、英國、西班牙、義大利、歐洲其他地區）、亞太地區（中國、日本、印度和其他亞太地區）、以及世界其他地區。隨著亞太地區目前經濟成長，醫療設施日益發達，包括疼痛管理在內的治療方法也越來越多。亞太地區的藥品生產也在成長，有多家國內和跨國公司參與生產和銷售鴉片類藥物。因此，隨著癌症、糖尿病等慢性疼痛疾病的出現以及人口老化，中國、印度和日本是受影響最嚴重的國家。

市場上營運的主要公司包括Purdue Pharma L.P.、Johnson &Johnson Services, Inc.、Teva Pharmaceutical Industries Ltd.、Endo, Inc.、Mallinckrodt company、Lannett、Pfizer Inc.、Amneal Pharmaceuticals LLC、Indivior PLC、Teikoku Seiyaku Co., Ltd.。

目錄

第1章 市場介紹

  • 市場定義
  • 主要目的
  • 利害關係人
  • 限制

第2章 研究方法或前提

  • 調查過程
  • 調查方法
  • 受訪者簡介

第3章 執行摘要

  • 行業概況
  • 依細分市場進行預測
    • 市場成長強度
  • 區域展望

第4章 市場動態

  • 促進因素
  • 機會
  • 抑制因素
  • 趨勢
  • PESTEL 分析
  • 需求方分析
  • 供給面分析
    • 併購
    • 投資場景
    • 產業洞察：主要新創公司及其獨特策略

第5章 價格分析

  • 區域價格分析
  • 影響價格的因素

第6章 全球羥考酮市場收入，2022-2032

第7章 依類型劃分的市場分析

  • 長效羥考酮
  • 短效羥考酮

第8章 應用市場分析

  • 疼痛管理
  • 戒癮

第9章 依通路劃分的市場分析

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第10章 依地區劃分的市場分析

  • 北美
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區

第11章 價值鏈分析

  • 邊際分析
  • 進入市場的公司名單

第12章 競爭態勢

  • 競爭儀表板
  • 競爭市場定位分析
  • 波特五力分析

第13章 公司簡介

  • Purdue Pharma L.P.
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Endo, Inc.
  • Mallinckrodt company
  • Lannett
  • Pfizer Inc.
  • Amneal Pharmaceuticals LLC
  • Indivior PLC
  • Teikoku Seiyaku Co.,Ltd.

第14章 首字母縮寫與先決條件

第15章 附錄

簡介目錄
Product Code: UMHE212902

Oxycodone is a potent opioid pain medication used to relieve moderate to severe pain. It works in the brain to change how your body feels and responds to pain. Oxycodone is often prescribed in extended-release forms for around-the-clock pain relief. This is due to its nature of being commonly abused and having addictive properties which is a controlled substance. Further, the existing opioid crisis has raised concerns about the opioid class of drugs, including Oxycodone, which may alter regulatory control and usage patterns. Moreover, the growing trend in the use of non-opioid and different pain management practices may have an impact on oxycodone demand in the future.

The Oxycodone Market is expected to grow with a significant CAGR of 5.13% during the forecast period (2024-2032). This can be attributed to the rising geriatric population coupled with the incidence of such chronic pain conditions as arthritis and back pain, and, therefore, the need for Opioid pain relievers like oxycodone also rises. The National Institutes of Health (NIH) (.gov) stated in the report that in 2023, new chronic pain cases were high, at 52.4 cases per 1,000 persons per year. This is compared to other common chronic conditions, such as diabetes (7.1 cases/1,000 per year), depression (15.9 cases/ 1,000 per year), and hypertension (45.3 cases/1,000 per year). Additionally, the growing demand for oxycodone has led to increased revenue for pharmaceutical companies producing and selling this medication.

Based on the type, the market has been divided into long-acting oxycodone and short-acting oxycodone. The long-acting oxycodone held a dominant share of the market in 2023. This is mainly helpful for those patients suffering from chronic pain like arthritis, cancer, and severe back pain that need long-term pain relief for them to have a good life. The ease and efficiency of using oxycodone have influenced prescribers to choose it over other forms of opioids, thus raising prescription rates.

Based on the application, the market is segmented into pain management and de-addiction. The pain management held a dominant share of the market in 2023. The rise in the prevalence of chronic illnesses like arthritis, fibromyalgia, and neuropathic pain has also contributed to the demand for pain relief products, which in turn has created the demand for oxycodone. For instance, from 2019 to 2021 in the United States (NHIS), around 5.4% of adults 18 to 44 years old reported arthritis, and Among adults aged 45 to 64 years, one-in-four (26.0%) reported doctor-diagnosed arthritis. Furthermore, improvements in the utilization of opioids for pain management and increasing awareness of the need to manage pain to enhance patient outcomes have made opioids such as oxycodone more accessible and appropriately used than in the past.

Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Hospitals are expected to grow with a significant CAGR in the forecast period (2024-2032). The higher incidence of surgeries and hospitalizations resulting from chronic and acute illnesses has also created a higher need for adequate pain relief in hospital environments, hence the need for oxycodone. For instance, according to the World Health Organisation, in 2023, over 300 million surgical procedures were performed each year worldwide. In addition, the hospital pharmacy provides an essential interface for educating patients about the proper use of opioids concerning the prescribed dosing and avoiding the risk of abuse.

For a better understanding of the market adoption of Oxycodone, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia-Pacific is expected to grow with a significant CAGR in the forecast period (2024-2032) because the region is currently witnessing economic growth; hence, there has been enhanced development of health facilities and enhanced availability of medical treatments, including therapies to manage pain. The Asia Pacific region is also growing in the production of pharmaceutical products, and several local and multinational companies are engaged in the production and marketing of opioid drugs. Thus, with the development of chronic pain conditions such as cancer and diabetes and an aging population, China, India, and Japan are the most affected nations.

Some of the major players operating in the market include Purdue Pharma L.P.; Johnson & Johnson Services, Inc.; Teva Pharmaceutical Industries Ltd; Endo, Inc.; Mallinckrodt company; Lannett; Pfizer Inc.; Amneal Pharmaceuticals LLC; Indivior PLC; Teikoku Seiyaku Co., Ltd.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Oxycodone Market
  • 2.2. Research Methodology of the Oxycodone Market
  • 2.3. Respondent Profile

3.EXECUTIVE SUMMARY

  • 3.1. Industry Synopsis
  • 3.2. Segmental Outlook
    • 3.2.1. Market Growth Intensity
  • 3.3. Regional Outlook

4.MARKET DYNAMICS

  • 4.1. Drivers
  • 4.2. Opportunity
  • 4.3. Restraints
  • 4.4. Trends
  • 4.5. PESTEL Analysis
  • 4.6. Demand Side Analysis
  • 4.7. Supply Side Analysis
    • 4.7.1. Merger & Acquisition
    • 4.7.2. Investment Scenario
    • 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

  • 5.1. Regional Pricing Analysis
  • 5.2. Price Influencing Factors

6.GLOBAL OXYCODONE MARKET REVENUE (USD BN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

  • 7.1. Long-acting oxycodone
  • 7.2. Short-acting oxycodone

8.MARKET INSIGHTS BY APPLICATION

  • 8.1. Pain Management
  • 8.2. De-addiction

9.MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 9.1. Hospital Pharmacies
  • 9.2. Retail Pharmacies
  • 9.3. Online Pharmacies

10.MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. France
    • 10.2.3. UK
    • 10.2.4. Spain
    • 10.2.5. Italy
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of APAC
  • 10.4. Rest of the World

11.VALUE CHAIN ANALYSIS

  • 11.1. Marginal Analysis
  • 11.2. List of Market Participants

12.COMPETITIVE LANDSCAPE

  • 12.1. Competition Dashboard
  • 12.2. Competitor Market Positioning Analysis
  • 12.3. Porter Five Forces Analysis

13.COMPANY PROFILES

  • 13.1. Purdue Pharma L.P.
    • 13.1.1. Company Overview
    • 13.1.2. Key Financials
    • 13.1.3. SWOT Analysis
    • 13.1.4. Product Portfolio
    • 13.1.5. Recent Developments
  • 13.2. Johnson & Johnson Services, Inc.
  • 13.3. Teva Pharmaceutical Industries Ltd
  • 13.4. Endo, Inc.
  • 13.5. Mallinckrodt company
  • 13.6. Lannett
  • 13.7. Pfizer Inc.
  • 13.8. Amneal Pharmaceuticals LLC
  • 13.9. Indivior PLC
  • 13.10. Teikoku Seiyaku Co.,Ltd.

14.ACRONYMS & ASSUMPTION

15.ANNEXURE